Results 31 to 40 of about 15,350 (196)
Profiling Co‐Occurrent Morphological Phenotypes and Their Degree of Expression Severity in Vacuolated Cells by Holo‐Tomographic Flow Cytometry and Fractal Analysis
Advanced Intelligent Systems, EarlyView.HTFC gets 3D refractive index tomograms of flowing cells. Label‐free monocytes are engineered to express patterns of cytoplasmic vacuoles. From the tomogram, an efficient dimensionality reduction is operated. Interpretable features are extracted to classify the expression severity of phenotypes coexisting in each cell, visually represented by a seven ...Marika Valentino, Giusy Giugliano, Daniele Pirone, Fabrizio Licitra, Fulvia Vitale, Pasquale Memmolo, Lisa Miccio, Massimo D’Agostino, Pietro Ferraro, Vittorio Bianco +9 morewiley +1 more sourceMucinous cystic neoplasms of the liver: A clinicopathological study and comparison with intraductal papillary neoplasms of the bile duct
, 2011 Mucinous cystic neoplasm of the liver has been a controversial entity, in particular, regarding differentiation from intraductal papillary neoplasm of the bile duct. In this study, we compared the characteristics of hepatic mucinous cystic neoplasms with Patcha V. R., Heaton N., Zamboni G., Pedica F., Capelli P., Quaglia A., Zen Y., Portmann B., Nakanuma Y., Casaril A. +9 morecore +1 more sourceGenitourinary Neuroendocrine Neoplasms
, 2020 Neuroendocrine neoplasms (NENs) of the genitourinary tract are uncommon, but the pathologist has to be prepared to recognize them and to assess the morphophenotypic factors that can drive their treatment and prognosis.Silvia Uccella, Xavier Mathias-Guiu, Uccella, Silvia, Stefano La Rosa, La Rosa, Stefano, Mathias-Guiu, Xavier +5 morecore +1 more sourceAnifrolumab Treatment Leads to Rapid Reduction in Urinary Biomarkers of Intrarenal Inflammation in Lupus Nephritis: Results From the Phase 2 Randomized Trial
Arthritis &Rheumatology, EarlyView.Objective
Lupus nephritis (LN) is one of the most severe manifestations of systemic lupus erythematosus (SLE) and is partially driven by type I interferon signaling. Anifrolumab, an approved treatment for patients with SLE, has been investigated in a phase 2 trial in patients with LN receiving standard therapy (TULIP‐LN, ClinicalTrials.gov identifier ...Andrea Fava, Michelle Petri, Patrick G. Gavin, Eszter Csomor, Philip Z. Brohawn, Daniel Muthas, Adam Platt, Catharina Lindholm, Nicola Ferrari +8 morewiley +1 more sourceClinical, dermoscopic and histopathological features of eccrine poroid neoplasms
, 2013 Background: Eccrine poroma (EP) belongs to the group of benign adnexal tumors, but cases of eccrine porocarcinoma (EPC) arising on long-standing and untreated EP suggest a certain risk of malignant transformation.Sgouros, Dimitris, ARGENZIANO, GIUSEPPE, Piana, Simonetta, Akalin, Taner, Zalaudek, Iris, LONGO, Caterina, Özdemir, Fezal, MOSCARELLA, ELVIRA, Karaarslan, Isil Kilinc +8 morecore +1 more sourceA Multifaceted Interplay Among Hemophagocytosis, Interleukin‐18, and Type I Interferon Distinguishes Still Disease From Other Autoinflammatory Diseases
Arthritis &Rheumatology, EarlyView.Objective
The unknown pathophysiology and the lack of specific features for systemic juvenile idiopathic arthritis and adult‐onset Still disease (collectively known as Still disease; SD) delay diagnosis and appropriate treatment. The goal of this study was to identify features and mechanisms that distinguish SD from other systemic autoinflammatory ...Yvonne M. Mueller, Charlotte Girard, Harmen J. G. van de Werken, Stefan J. Erkeland, Dwin G. B. Grashof, Laurie Vaillant, Renske J. H. den Dekker, Iris van Zuijen, Sharon Veenbergen, Fanny Coffin, Eric Bindels, Yvan Jamilloux, Katerina Laskari, Vassili Soumelis, Bruno Fautrel, Cem Gabay, Peter D. Katsikis +16 morewiley +1 more sourceENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: colorectal neuroendocrine neoplasms.
, 2012 ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: colorectal neuroendocrine ...O'Connor J, Baum R, Cadiot G, K. J. Klose, Grossman A, Sauvanet A, Scoazec JY, Bartsch D, Delle Fave G, Costa F, Pascher A, Brandi ML, Salazar R, Kianmanesh R, Plöckinger U, Klose KJ, Knigge U, Baudin E, Sundin A, Kelestimur F, FALCONI , MASSIMO, O. Nillson, M. Papotti, R. Salazar, Denecke T, Klöppel G, M. Caplin, Perren A, Eriksson B, F. Kelestimur, de Herder W, A. Sundin, Kwekkeboom D, Krenning E, Komminoth P, Ruszniewski P, Pavel M, Taal B, Vullierme MP, Nilsson O, Niederle B, Kos Kudla B, Arnold R, Rindi G, Tomassetti P, FALCONI, Massimo, Couvelard A, A. Pascher, Van Cutsem E, Öberg K, Jensen R, Sasano H, Caplin M, B. C. Conference Anlauf M, Wiedenmann B., U. Plöckinger, Gress T, Lopes JM, O'Toole D, Steinmüller T, Papotti M, Kaltsas G, Pape UF, Gross D, R. P. Baum +64 morecore +1 more sourceIntraductal papillary mucinous neoplasms of the pancreas with concurrent pancreatic and periampullary neoplasms
, 2016 Intraductal papillary mucinous neoplasms (IPMN) have been reported to be associated with concurrent, distinct pancreatic ductal adenocarcinoma (con-PDAC) in about 8% (range, 4-10%) of resected branch duct (BD) lesions.Ferrone C, CRIPPA, STEFANO, Warshaw AL, Mino Kenudson M, Fernandez Del Castillo C., FALCONI , MASSIMO, Zamboni G, Sahora K, Lillemoe K +8 morecore +1 more sourceTNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study [PDF]
, 2012 Both the European Neuroendocrine Tumor Society (ENETS) and the International Union for Cancer Control/American Joint Cancer Committee/World Health Organization (UICC/AJCC/WHO) have proposed TNM staging systems for pancreatic neuroendocrine neoplasms ...Komminoth, P, G. Rindi, Boninsegna, L, de Krijger, R R, La Rosa, S, P. Komminoth, Perren, A, S. L. Rosa, DELLE FAVE, Gianfranco, Delle Fave G, Pape, U, C. Klersy, G. Fusai, Klersy, C, Rindi, Guido, R. R. De, L. Albarello, Luong, TV, A. Perren, Couvelard, A, Klersy C, A. Schmitt, Luong TV, Wiedenmann, B, Scarpa, Alessandra, de Herder, W W, FALCONI , MASSIMO, A. Scarpa, Ruszniewski, P, M. Caplin, Falconi M, Fusai G, Perren A, A. Couvelard, Buchler, M W, Luong, T V, Schmitt, A, Fisher L, Fischer L, Komminoth P, Ruszniewski P, Wiedenmann B, C. Doglioni, Capella C, Fischer, L, Fusai, G, Buchler MW, de Herder, W.W., de Krijger, Ronald, Doglioni, C, Rindi G, Jann, H, Couvelard A, T. V. Luong, Boninsegna L, Buchler, MW, FALCONI, MASSIMO, U. Pape, M. Falconi, Scarpa, A, W. W. De, Caplin, M, La Rosa S, Caplin M, Rindi, G, E. Solcia, Wiedenmann B., Delle Fave, G, L. Fischer, Capella, C, Albarello L, DOGLIONI , CLAUDIO, Albarello, L, L. Boninsegna, Jann H, M. W. Buchler, Doglioni C, Solcia, E, Falconi, M, C. Capella, B. Wiedenmann, SCARPA, Aldo, H. Jann, de Herder WW, Pape U, Solcia E, P. Ruszniewski, Scarpa A, de Krijger RR, Schmitt A +89 morecore +1 more source